Publication ethics | AmViMed Publishers
AmViMed Publishers expects authors, editors, and reviewers to uphold research integrity, transparent reporting, and fair editorial behavior across the full publication lifecycle. Authorship and originality: All listed authors must have made a meaningful scholarly contribution, approved the submitted version, and agreed
AmViMed Publishers expects authors, editors, and reviewers to uphold research integrity, transparent reporting, and fair editorial behavior across the full publication lifecycle.
Authorship and originality
All listed authors must have made a meaningful scholarly contribution, approved the submitted version, and agreed to publication under the journal’s policies. Submissions must be original, not under duplicate consideration, and must accurately cite prior work, reused data, and adapted material.
Research integrity and data transparency
Authors should retain supporting data, document methods clearly, disclose study limitations, and provide ethics approvals, consent statements, and funding disclosures where relevant. Editors may request clarifications, raw materials, or corrections where reported findings appear incomplete, misleading, or inconsistent.
Conflicts of interest
Authors, reviewers, and editors must disclose financial, professional, or personal interests that could reasonably influence editorial judgment or interpretation of findings. Undisclosed conflicts may lead to reassignment, correction, or post-publication action.
Corrections, expressions of concern, and retractions
Where issues are identified after publication, AmViMed Publishers may issue corrections, editorial notes, expressions of concern, or retractions depending on severity and evidentiary support. Retraction status is surfaced in the article interface so readers can quickly assess record reliability.